CION Ameerpet
FNAC — fine-needle aspiration cytology — is a quick, minimally invasive test that uses a very thin needle to draw a few cells from a breast lump so a pathologist can check them under a microscope. It is fast, low-cost, and needs no cuts or stitches. At CION Cancer Clinics in Hyderabad, FNAC is part of a proper triple assessment, and every result is reviewed by a tumor board — so you get a clear answer, not just a slide report.
FNAC stands for fine-needle aspiration cytology. It is a simple diagnostic test in which a doctor passes a very thin needle — finer than the one used to draw blood — into a breast lump and gently draws out (aspirates) a small sample of cells. Those cells are smeared onto a glass slide and examined under a microscope by a cytopathologist. The word cytology means the study of individual cells, which is exactly what FNAC looks at.
The purpose is to find out, quickly and with very little discomfort, whether a breast lump is most likely benign (non-cancerous, such as a fibroadenoma or a cyst), suspicious, or malignant (cancer). Because the needle is so fine, FNAC usually needs no cut, no stitches and often no anaesthetic injection, and you can go home straight away.
FNAC is widely used across Hyderabad because it is fast and inexpensive. But an important principle guides how we use it at CION: FNAC is one part of a triple assessment — read alongside the clinical examination and imaging (ultrasound or mammogram). It gives a strong early signal, but it is interpreted in context, never as a stand-alone verdict.
In a published comparative study of palpable breast lumps, FNAC reached about 75% overall diagnostic accuracy, while core needle biopsy reached roughly 88% — and combining the two raised accuracy to about 88% as well. This is exactly why FNAC is read as one part of a triple assessment, never as a stand-alone verdict on a lump. Source: comparative FNAC vs core needle biopsy study of palpable breast lumps (PMC9441185, NIH/NCBI).
This is the question most people ask, so here is the honest answer: FNAC and core needle biopsy are both ways of sampling a breast lump, but they collect different things and answer different questions. FNAC draws out loose cells (cytology). A core needle biopsy (CNB) uses a slightly thicker, spring-loaded needle to remove a tiny core of tissue (histology), which keeps the architecture of the tissue intact. That extra detail lets the lab tell invasive cancer apart from in-situ cancer and run the receptor tests (ER, PR, HER2) that guide treatment — something FNAC cannot reliably do.
| Aspect | FNAC (cytology) | Core Needle Biopsy (histology) |
|---|---|---|
| What is collected | Loose cells | A small core of intact tissue |
| Needle | Very thin | Thicker, spring-loaded |
| Anaesthesia | Usually none | Local anaesthetic |
| Tells invasive vs in-situ? | No | Yes |
| ER / PR / HER2 receptor testing? | Not reliably | Yes |
| Cost & speed | Lowest cost, fastest | Slightly more, still same-day |
| Diagnostic accuracy (palpable lump) | ~75% | ~88% |
So when is each used? See below — and remember, this is decided by your specialist after the clinical exam and scan, not by a fixed rule.
The lump is easy to feel, looks likely benign, or for a quick check of a cyst, a lymph node, or a recurrence at a scar — FNAC is fast, very low cost, and almost painless, making it ideal for a first-line answer in a busy clinic setting.
Cancer is suspected and treatment planning is needed — because CNB can confirm invasive cancer, grade it, and run ER, PR and HER2 receptor tests on the same sample, current breast guidelines favour it as the definitive tissue diagnosis before any cancer surgery or chemotherapy decision.
If a fine-needle sample does not have enough cells or the result is borderline, a core needle biopsy is the usual next step rather than repeating FNAC — it minimises the risk of a missed diagnosis and gives the tissue detail FNAC could not.
Studies show the combined accuracy of FNAC plus core biopsy is higher than either alone — the two complement each other, which is why a thorough work-up sometimes uses both before a final decision is made.
An FNAC of the breast is one of the quickest tests in the clinic. There is no fasting, no injection to prepare for, and the sampling itself usually takes only a few minutes. If the lump can be felt easily, the doctor may do it by hand; if it is small or deep, an ultrasound-guided FNAC is used so the needle goes exactly to the right spot. Here is what to expect, step by step.
You lie or sit comfortably with the arm raised. The skin over the lump is cleaned with an antiseptic so the area is sterile before the needle is passed.
The doctor steadies the lump between two fingers. For a small or deep lump, a live ultrasound scan is used to guide the needle precisely — this is called ultrasound-guided FNAC.
A very fine needle attached to a syringe is inserted into the lump and moved back and forth a few times to draw a small sample of cells. You may feel a brief pinch or pressure, but it is over in seconds.
The cells are spread thinly onto glass slides and fixed. A few passes may be taken to make sure there are enough cells for a confident reading.
Light pressure or a small dressing is applied. There are usually no stitches. You can return to normal activity the same day; a little bruising or tenderness is normal and settles quickly.
A specialist cytopathologist examines the slides under a microscope. At CION, the report is read by our specialists and, where needed, taken to the tumor board so the result is interpreted in full clinical context.
We're never more than 30 minutes away. Same panel of specialists at every centre. Same tumour board reviews. Same NCCN protocols. Pick the closest one and call directly — or let us pick for you.
CION Ameerpet
CION Kukatpally
CION L.B. Nagar
CION Tolichowki
CION Masab Tank
CION Banjara Hills
CION Kompally
CION Balanagar
CION Siddipet
CION Sangareddy
Not sure which centre fits best? Tell us where you are — we'll suggest the closest one with the right specialists.
Help me pick the right centreTravelling for treatment? We may have a centre right where you are.
Don't see your city? Call 18002028726 — we'll find your nearest CION partner centre.
Trained at AIIMS, Tata Memorial, and leading international centres. Combined 150+ years of experience. Every complex case is reviewed by 3+ of them — together.
MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)
MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)
MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)
MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)
MBBS, MS(General Surgery), M.Ch(Surgical Oncology), FMAS, FARIS(Ongoing)
MBBS, MS (General Surgery), DrNB (Surgical Oncology), FALS Oncology
Want a specific doctor for your case? Mention them when booking.
Book Free ConsultationShare your name and number — we'll call you back within 30 minutes to schedule your consultation.
Confidential, doctor-led, and free for your first consultation. Call us on 1800-202-8726 or request a callback — we'll guide your next step.
Understanding the limits of FNAC is just as important as understanding its strengths — it protects you from both false reassurance and unnecessary worry. FNAC looks at loose cells (cytology). A core biopsy looks at intact tissue (histology). That single difference explains almost everything FNAC can and cannot do. Used in the right situation, FNAC gives a fast, reliable steer; used as a stand-alone cancer verdict, it can mislead — which is why we always read it within a triple assessment.
When the cells are clearly benign and match a simple cyst or fibroadenoma seen on the scan and felt on exam, FNAC can give quick, strong reassurance and often saves you from a more involved biopsy.
A skilled cytopathologist can identify cancer cells with high confidence, giving an early warning that lets your care team move quickly to the next, confirmatory step.
FNAC is very useful for checking an enlarged underarm lymph node or a lump at an old surgical scar, where a quick cell sample answers a focused question.
Because FNAC has only loose cells and not intact tissue, it cannot tell whether a cancer is contained (in-situ, like DCIS) or has begun to invade — a distinction that changes treatment and needs a core biopsy.
The receptor tests that decide whether hormone therapy or targeted drugs like trastuzumab will help are run on tissue. A core biopsy is needed for these, so FNAC alone is not enough to plan cancer treatment.
Tumour grade — how aggressive the cancer looks — depends on tissue architecture that FNAC cannot fully show, so a core or surgical biopsy is used to grade and stage accurately.
How accurate is FNAC of the breast? In experienced hands, with a good sample and a skilled cytopathologist, it is a reliable first-line test. In a published comparative study of palpable breast lumps, FNAC showed around 74% sensitivity, 77% specificity and 75% overall diagnostic accuracy, while core needle biopsy reached roughly 85% sensitivity, 93% specificity and 88% accuracy. When both tests were combined, accuracy rose to about 88%, which is why the two are seen as complementary.* The accuracy of any FNAC depends heavily on three things: the size and location of the lump, the number and quality of the passes taken, and the experience of the cytopathologist reading the slides.
Sometimes FNAC comes back inadequate (too few cells) or inconclusive (the cells are borderline — neither clearly benign nor clearly malignant). This is not a cause for panic; it simply means the test could not give a confident answer. The right response is a calm, structured next step.
When the cells look benign but the exam or scan is still worrying (a "discordant" result on triple assessment), we do not simply stop — a core needle biopsy is done to be certain, because the imaging and clinical picture must agree before we relax.
Too few cells means no answer, not a bad one. The usual next step is a core needle biopsy rather than repeating FNAC, since CNB gives intact tissue and is far less likely to come back inadequate.
A borderline result is moved forward, not left hanging — a core biopsy confirms whether cancer is present and, if so, provides the grade and receptor tests needed to plan treatment properly.
Even a clear malignant FNAC is usually followed by a core biopsy before treatment, because the receptor testing and invasive-versus-in-situ detail it provides are essential to choosing surgery, chemotherapy or targeted therapy.
*Diagnostic accuracy figures from a comparative FNAC vs core needle biopsy study of palpable breast lumps (PMC9441185, NIH/NCBI). Figures vary between centres and operators.
One reason FNAC is so widely used is that it is the most affordable way to sample a breast lump. As a guide, a standard FNAC in Hyderabad typically costs between Rs. 800 and Rs. 2,400, and an ultrasound-guided FNAC usually costs around Rs. 2,000 to Rs. 3,500, depending on the centre, the cytopathologist's expertise, the number of passes, and whether imaging guidance is needed. A core needle biopsy, when required, is priced separately and is modestly higher. We believe in transparent costs and no unnecessary tests — you will know what a test costs and exactly why it is recommended before you commit to anything.
CION runs a network of diagnostic and PET-CT centres across Hyderabad, with up to 50% off on diagnostics for cancer patients and expert-reviewed reporting. Your first consultation is free. To book an FNAC, request a cost estimate, or have an existing FNAC or biopsy report reviewed by our specialists, simply request a callback — we will guide you on whether FNAC, a core biopsy, or both is the right next step.
Roughly Rs. 800 to Rs. 2,400 in Hyderabad — the lowest-cost way to sample a breast lump.
Around Rs. 2,000 to Rs. 3,500 when imaging guidance is needed for a small or deep lump.
Concessional diagnostic pricing for cancer patients, with expert-reviewed reports.
Cashless private insurance and EMI support available — ask our team for help.
A cell sample is only as good as the team interpreting it. At CION Cancer Clinics, FNAC is never read in isolation — it is part of a proper triple assessment, where three things are weighed together: the clinical examination, the imaging (ultrasound or mammogram), and the cytology or biopsy. When all three agree, you get a confident answer. When they disagree, we investigate further rather than guess. Where anything is uncertain, your case goes to our tumor board, where medical, surgical and radiation oncologists review it together — decisions made by a team, not a single opinion, explained to you in a 45-minute consultation.
As a woman-headed organisation, breast and women's-health care sits at the heart of what we do, and our outcomes reflect it: CION patients see a 1-year breast cancer survival of 96.9% versus the national average of 85.4% — an 11.5 percentage-point difference.* If your FNAC is clearly benign and everything agrees, we will tell you so and reassure you. If it needs a closer look, we will walk that path with you, step by step — no rushed decisions, no unnecessary tests.
A panel of 17 super-specialist oncologists across medical, surgical and radiation oncology.
FNAC read alongside the clinical exam and imaging — never a stand-alone verdict on a lump.
A trusted network across Telangana and AP, rated 4.8/5 by patients on Google.
Transparent costs, no unnecessary tests, and a free first consultation for all cancer patients.
*1-year survival. Source: ICMR / National Cancer Registry Programme (NCRP), compared with CION patient outcomes. National figures are population averages and do not predict an individual's result.
From a quick lump check to full breast cancer care — hear how our patients were guided with clarity, not pressure.
These aren't paid endorsements or written reviews. These are video testimonials from real patients and families — recorded on their own phones, in their own words. Pick any one. Watch it. Then decide.
Read all 800+ reviews on Google
Start Your Story. Book Free Consultation.For most people FNAC causes only brief, mild discomfort — similar to or less than a blood test, because the needle used is finer. You may feel a quick pinch or a little pressure as the needle goes into the lump, and the sampling lasts only a few seconds per pass. Many FNACs are done without any anaesthetic injection. Afterwards, some mild bruising or tenderness at the site is normal and settles within a day or two. If the lump is sensitive, a small amount of local anaesthetic can be used. Overall, FNAC is one of the most patient-friendly ways to check a breast lump.
FNAC (fine-needle aspiration cytology) uses a very thin needle to draw out loose cells, which are examined as cytology. A core needle biopsy uses a slightly thicker needle to remove a small core of intact tissue, examined as histology. The key difference is detail: a core biopsy keeps the tissue structure intact, so it can tell invasive cancer from in-situ cancer and run ER, PR and HER2 receptor tests that guide treatment. FNAC is faster and cheaper and is excellent as a first-line check, but it cannot reliably do those treatment-planning tests. Your specialist chooses based on the lump, the scan and the clinical picture.
Yes — FNAC can detect cancer cells in a breast lump, and a skilled cytopathologist can identify malignant cells with high confidence. In studies of palpable breast lumps, FNAC showed roughly 74% sensitivity and 75% overall accuracy. However, no needle test alone confirms cancer with complete certainty. A clearly malignant FNAC is usually followed by a core needle biopsy before treatment, because the biopsy confirms whether the cancer is invasive and provides the receptor tests needed to plan therapy. At CION, FNAC is always read within a triple assessment alongside the clinical exam and imaging.
In experienced hands with a good sample, FNAC is a reliable first-line test. A published comparative study of palpable breast lumps reported FNAC at around 74% sensitivity, 77% specificity and 75% overall accuracy, while core needle biopsy reached about 85%, 93% and 88% respectively. Combining both raised accuracy to roughly 88%. Accuracy depends on the lump's size and location, the number and quality of needle passes, and the cytopathologist's experience. This is why FNAC is interpreted as part of a triple assessment rather than alone, and why an unclear FNAC is followed by a core biopsy rather than treated as a final answer.
An inconclusive or inadequate FNAC simply means the test could not give a confident answer — usually because there were too few cells or the cells were borderline. It is not a cause for alarm. The standard next step is a core needle biopsy rather than repeating the FNAC, because a core biopsy provides intact tissue and is far less likely to come back inadequate. If FNAC looked benign but your exam or scan is still worrying, a core biopsy is also done to be certain. At CION, any discordant or unclear result is moved forward through the tumor board so nothing is left hanging.
In Hyderabad, a standard breast FNAC typically costs between Rs. 800 and Rs. 2,400, while an ultrasound-guided FNAC usually costs around Rs. 2,000 to Rs. 3,500. The exact price depends on the centre, the cytopathologist's expertise, the number of passes taken, and whether imaging guidance is needed. A core needle biopsy, when required, is charged separately and is modestly higher. At CION we keep costs transparent and offer up to 50% off diagnostics for cancer patients, with expert-reviewed reports. Your first consultation is free — request a callback for an exact estimate.
FNAC needs very little preparation. You do not need to fast, and there is no injection to prepare for. Wear comfortable, two-piece clothing so you only need to undress from the waist up, and tell your doctor about any blood-thinning medicines or bleeding tendency, as these may need a brief check first. The sampling itself takes only a few minutes; with cleaning and slide preparation, the whole appointment is usually under 20 minutes. You can go home and resume normal activity straight away. At CION, results are explained to you by a specialist rather than simply handed over.
A triple assessment means a breast lump is checked three ways — by clinical examination, by imaging (ultrasound or mammogram), and by a needle sample (FNAC or core biopsy). FNAC is done as one of those three parts because, on its own, cytology cannot tell invasive from in-situ cancer or run treatment-planning tests, and a single test can occasionally mislead. When all three parts agree, the diagnosis is highly reliable. When they disagree, it signals that more investigation is needed before any decision. At CION, this structured approach protects you from both false reassurance and unnecessary treatment, with uncertain cases reviewed by our tumor board.